Previous 10 | Next 10 |
Kajima Corporation ADR (KAJMY) is expected to report for quarter end 2023-12-31 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 BrewBilt MFG Inc (BBRW) is expected to report for Q4 2023 Correlate Energy Corp. (CIPI) is expected to report for Q4 2023 Hyzon Motors Inc. (...
ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...
2024-01-25 16:34:19 ET More on Titan Pharmaceuticals Financial information for Titan Pharmaceuticals Read the full article on Seeking Alpha For further details see: Titan pharmaceuticals notified of full compliance by NASDAQ
SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that by letter dated January 24, 2024, the Company was notified by The Nasdaq Stock Market LLC that the Company has rega...
2024-01-09 12:43:25 ET Gainers: Neximmune NEXI +96% . Sentage Holdings SNTG +58% . Mountain Crest Acquisition Corp IV MCAF +48% . Zoomcar Holdings ZCAR +42% . Cutera CUTR +37% . Adicet Bio ( ACET ) +33% . Solid Biosciences ( SLDB ...
2024-01-08 08:02:08 ET Titan Pharmaceuticals, Inc. (de) (TTNP) announced stock split at a ratio of 1-for-20 on 2024-01-09 ... Full story available on KlickAnalytics.com
2023-12-28 16:30:57 ET More on Titan Pharmaceuticals Financial information for Titan Pharmaceuticals For further details see: Titan Pharmaceuticals to conduct 1-for-20 reverse stock split
SOUTH SAN FRANCISCO, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that its Board of Directors has approved a 1-for-20 reverse stock split of the Company's common stock, which will be eff...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Titan Pharmaceuticals Inc. (TTNP) is expected to report for Q1 2024
News, Short Squeeze, Breakout and More Instantly...
Titan Pharmaceuticals Inc. Company Name:
TTNP Stock Symbol:
NASDAQ Market:
Titan Pharmaceuticals Inc. Website:
2024-05-06 18:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of common stock. A...
BioHarvest Sciences Inc (CNVCF) is expected to report for quarter end 2023-12-31 QS Energy Inc (QSEP) is expected to report for Q4 2023 NKGen Biotech Inc. (NKGN) is expected to report for Q4 2023 Cal-Maine Foods Inc. (CALM) is expected to report for Q3 2024 Davide Campari (DVDCF) ...